146 related items for PubMed ID: 23155688
1. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
Bonfig W, Schwarz HP.
J Pediatr Endocrinol Metab; 2012; 25(7-8):645-9. PubMed ID: 23155688
[Abstract] [Full Text] [Related]
2. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
Horm Res; 2001; 55(4):161-71. PubMed ID: 11598369
[Abstract] [Full Text] [Related]
3. Final height of patients with classical congenital adrenal hyperplasia.
Aycan Z, Akbuğa S, Cetinkaya E, Ocal G, Berberoğlu M, Evliyaoğlu O, Adiyaman P.
Turk J Pediatr; 2009; 51(6):539-44. PubMed ID: 20196386
[Abstract] [Full Text] [Related]
4. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
[Abstract] [Full Text] [Related]
5. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
J Pediatr; 2015 Mar; 166(3):743-50. PubMed ID: 25557963
[Abstract] [Full Text] [Related]
6. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
[Abstract] [Full Text] [Related]
7. Growth pattern of untreated boys with simple virilizing congenital adrenal hyperplasia indicates relative androgen insensitivity during the first six months of life.
Bonfig W, Schwarz HP.
Horm Res Paediatr; 2011 Nov; 75(4):264-8. PubMed ID: 21196707
[Abstract] [Full Text] [Related]
8. [Auxological data and definitive height in short patients without hormonal deficiencies. A longitudinal study].
Tassoni P, Colli C, Paterra RA, Mandini M, Tosi M, Parisi G, Viti A, Cacciari E.
Pediatr Med Chir; 1991 Nov; 13(6):565-8. PubMed ID: 1806912
[Abstract] [Full Text] [Related]
9. [Accuracy of the methods for height prediction in patients treated for congenital primary hypothyroidism].
Bueno Lozano G, Ruibal Francisco JL, Reverte Blanc F, Casado de Frías E.
An Esp Pediatr; 1997 Dec; 47(6):595-600. PubMed ID: 9575118
[Abstract] [Full Text] [Related]
10. [Growth and adult height in patients with congenital adrenal hyperplasia].
Kolousková S, Zemková D, Snajderová M, Lebl J.
Cas Lek Cesk; 1995 Nov 01; 134(21):689-91. PubMed ID: 8556761
[Abstract] [Full Text] [Related]
11. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
J Clin Endocrinol Metab; 2009 Oct 01; 94(10):3882-8. PubMed ID: 19622620
[Abstract] [Full Text] [Related]
12. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
[Abstract] [Full Text] [Related]
13. The validity of the Bayley-Pinneau method in predicting final adult height at the onset of puberty in patients with classic congenital adrenal hyperplasia.
Badawi N, Fawaz L, Amin A, Kamel A, Arafa N.
Endokrynol Pol; 2021 Dec 01; 72(4):301-307. PubMed ID: 34010438
[Abstract] [Full Text] [Related]
14. Growth patterns in the first three years of life in children with classical congenital adrenal hyperplasia diagnosed by newborn screening and treated with low doses of hydrocortisone.
Bonfig W, Schmidt H, Schwarz HP.
Horm Res Paediatr; 2011 Dec 01; 75(1):32-7. PubMed ID: 20714115
[Abstract] [Full Text] [Related]
15. Treatment and disease effects on short-term growth and adult height in children and adolescents with 21-hydroxylase deficiency.
Hauffa BP, Winter A, Stolecke H.
Klin Padiatr; 1997 Dec 01; 209(2):71-7. PubMed ID: 9113619
[Abstract] [Full Text] [Related]
16. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
J Pediatr; 2002 Aug 01; 141(2):247-52. PubMed ID: 12183722
[Abstract] [Full Text] [Related]
17. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
Endocr Pract; 2017 May 01; 23(5):546-556. PubMed ID: 28225306
[Abstract] [Full Text] [Related]
18. Experience with long-term glucocorticoid treatment in congenital adrenal hyperplasia: growth pattern compared with genetic height potential.
Aycan Z, Ocal G, Berberoglu M, Cetinkaya E, Adiyaman P, Evliyaoglu O.
J Pediatr Endocrinol Metab; 2006 Mar 01; 19(3):245-51. PubMed ID: 16607925
[Abstract] [Full Text] [Related]
19. [Final height in 69 patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency].
David M, Sempé M, Blanc M, Nicolino M, Forest MG, Morel Y.
Arch Pediatr; 1994 Apr 01; 1(4):363-7. PubMed ID: 7842090
[No Abstract] [Full Text] [Related]
20. [Puberty and growth development in patients with a 21-hydroxylase defect].
Börger D, Willig RP.
Monatsschr Kinderheilkd; 1985 Nov 01; 133(11):828-33. PubMed ID: 2934617
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
